Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant
Clinical trial NCT02550639 · COMPLETED
Trial details
- NCT number
- NCT02550639
- Sponsor
- ORIOL BESTARD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2018-09-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.